ReviewExpert opinion on biological therapy2022

Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?

Gunay Uludag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.